The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Artificial intelligence in drug development: present status and future prospects
Abstract
Artificial intelligence (AI) uses personified knowledge and learns from the solutions it produces to address not only specific but also complex problems. Remarkable improvements in computational power coupled with advancements in AI technology could be utilised to revolutionise the drug development process. At present, the pharmaceutical industry is facing challenges in sustaining their drug development programmes because of increased R&D costs and reduced efficiency. In this review, we discuss the major causes of attrition rates in new drug approvals, the possible ways that AI can improve the efficiency of the drug development process and collaboration of pharmaceutical industry giants with AI-powered drug discovery firms.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Many more examples are available [3,32,33,34,35,36,37], showing that AI-based methods can accelerate the drug discovery process and enable the development of more effective medications.”
From The role of AI in drug discovery: challenges, opportunities, and strategies (2023) · cites this paper as [36]
Citations
Cites
Artificial intelligence in healthcare: past, present and future
Jiang, F., Jiang, Y., Zhi, H., Dong, Y., Li, H., Ma, S., Wang, Y., Dong, Q., Shen, H., & Wang, Y. (2017) · Stroke and Vascular Neurology · doi:10.1136/svn-2017-000101 · Cited by 4,837
Can the pharmaceutical industry reduce attrition rates?
Kola, I., & Landis, J. (2004) · Nature Reviews Drug Discovery · doi:10.1038/nrd1470 · Cited by 4,167
Principles of early drug discovery
Hughes, J., Rees, S., Kalindjian, S., & Philpott, K. (2011) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2010.01127.x · Cited by 2,859
Artificial intelligence in medicine
Hamet, P., & Tremblay, J. (2017) · Metabolism · doi:10.1016/j.metabol.2017.01.011 · Cited by 2,334
Diagnosing the decline in pharmaceutical R&D efficiency
Scannell, J. W., Blanckley, A., Boldon, H., & Warrington, B. (2012) · Nature Reviews Drug Discovery · doi:10.1038/nrd3681 · Cited by 1,981
Planning chemical syntheses with deep neural networks and symbolic AI
Segler, M. H. S., Preuss, M., & Waller, M. P. (2018) · Nature · doi:10.1038/nature25978 · Cited by 1,847
The rise of deep learning in drug discovery
Chen, H., Engkvist, O., Wang, Y., Olivecrona, M., & Blaschke, T. (2018) · Drug Discovery Today · doi:10.1016/j.drudis.2018.01.039 · Cited by 1,770
Generating Focused Molecule Libraries for Drug Discovery with Recurrent Neural Networks
Segler, M. H. S., Kogej, T., Tyrchan, C., & Waller, M. P. (2018) · ACS Central Science · doi:10.1021/acscentsci.7b00512 · Cited by 1,537
Deep Learning in Medical Imaging: General Overview
Lee, J., Jun, S., Cho, Y.-W., Lee, H., Kim, G. B., Seo, J. B., & Kim, N. (2017) · Korean Journal of Radiology · doi:10.3348/kjr.2017.18.4.570 · Cited by 1,328
Organs-on-chips at the frontiers of drug discovery
Esch, E. W., Bahinski, A., & Huh, D. (2015) · Nature Reviews Drug Discovery · doi:10.1038/nrd4539 · Cited by 1,185
Flagged first, then by citations
Cited by
Sorted by citations
Items 501–600 of 1,000
Artificial Intelligence: A New Era in Drug Discovery
Mishra, D. K., & Awasthi, H. (2021) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v9i5.995 · Cited by 7
Artificial intelligence (AI) and machine learning in the treatment of various diseases
Mittal, P., Goyal, R., Kapoor, R., & Gautam, R. K. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-99137-7.00010-1 · Cited by 5
SEmHuS: a semantically embedded humanitarian space
Shamoug, A., Cranefield, S., & Dick, G. (2023) · Journal of International Humanitarian Action · doi:10.1186/s41018-023-00135-4 · Cited by 6
Role of artificial intelligence in pharmaceutical health care
Lu, K. (2024) · Journal of the American Pharmacists Association · doi:10.1016/j.japh.2023.12.012 · Cited by 6
Integrating Transformer-based Language Model for Drug Discovery
Kotkondawar, R. R., Sutar, S. R., Kiwelekar, A. W., & Kadam, V. J. (2024) · International Conference on Computing for Sustainable Global Development · doi:10.23919/indiacom61295.2024.10498263 · Cited by 6
Drug Discovery and Development from Ethnomedicinal Plants in the Artificial Intelligence Era
Mesta, S. C., Kumar, J. S., Elayaperumal, S., & Meenakumari, H. R. (2024) · Springer eBooks · doi:10.1007/978-981-97-3405-4_21 · Cited by 7
Strategic partnerships for AI-driven drug discovery: The role of relational dynamics
Kint, S., Dolfsma, W. A., & Robinson, D. (2024) · Drug Discovery Today · doi:10.1016/j.drudis.2024.104242 · Cited by 8
Patel, P., Kumari, D., Jain, A., Gupta, R., & Mishra, H. K. (2024) · International Journal of Pharmaceutical Sciences and Nanotechnology · doi:10.37285/ijpsn.2024.17.6.6 · Cited by 5
Kim, S., Yang, S., Jung, J., Choi, J., Kang, M., & Joo, J. (2025) · Advanced Science · doi:10.1002/advs.202413786 · Cited by 5
When the drugs (don’t) work: The role of science in product commercialization
Anckaert, P. (2025) · Research Policy · doi:10.1016/j.respol.2025.105237 · Cited by 5
Gomase, V. S., Ghatule, A. P., Sharma, R., & Sardana, S. (2025) · Reviews on Recent Clinical Trials · doi:10.2174/0115748871366467250413070850 · Cited by 6
Stitou, M., Toufik, H., Bouachrıne, M., Bih, H., & Lamchouri, F. (2019) · International Conference on Intelligent Systems and Advanced Computing Sciences (ISACS) · doi:10.1109/isacs48493.2019.9068917 · Cited by 5
Protein Structure, Dynamics and Assembly: Implications for Drug Discovery
Yazhini, A., Chakraborti, S., & Srinivasan, N. (2021) · Springer eBooks · doi:10.1007/978-981-15-8936-2_5 · Cited by 5
An Efficient Drug Design Method Based on Drug-Target Affinity
Liu, H., Zhang, X., Lin, X., & Hu, J. (2023) · Lecture notes in computer science · doi:10.1007/978-981-99-4749-2_65 · Cited by 5
Neuronal Circuit-Based Computer Modeling as a Phenotypic Strategy for CNS R&D
Geerts, H., & Barrett, J. E. (2019) · Frontiers in Neuroscience · doi:10.3389/fnins.2019.00723 · Cited by 5
Human Forest vs. Random Forest in Time-Sensitive COVID-19 Clinical Trial PredictionPreprint
Atanasov, P. D., Joseph, R., Feijoo, F., Marshall, M., Conway, A., & Siddiqui, S. (2021) · SSRN Electronic Journal · doi:10.2139/ssrn.3981732 · Cited by 6
Rani, I., Munjal, K., Singla, R. K., & Gautam, R. K. (2023) · Wiley eBooks · doi:10.1002/9781119865728.ch2 · Cited by 5
Bansal, S., & Sindhi, V. (2025) · doi:10.1002/9781394269969.ch14 · Cited by 5
The Impact of Artificial Intelligence on Pharmacy Education, Research and Practice
Kakade, P. A., Sontakke, S. M., Hosmani, A. H., & Gonjari, I. D. (2025) · Asian Journal of Pharmaceutical Research · doi:10.52711/2231-5691.2025.00051 · Cited by 4
Pharmacy Students’ Perspectives on Integrating Generative AI into Pharmacy Education
Alexander, K. M., Jorgensen, E. O., Rowe, C., & Nguyen, K. A. (2025) · Pharmacy · doi:10.3390/pharmacy13060183 · Cited by 5
Dominici, G., & Yolles, M. I. (2026) · Technological Forecasting and Social Change · doi:10.1016/j.techfore.2026.124584 · Cited by 4
Status of the Indian biopharmaceutical industry and way forward to be a dominant global player
Ghosh, P. (2023) · MGM Journal of Medical Sciences · doi:10.4103/mgmj.mgmj_106_23 · Cited by 4
AI and machine learning in pharmaceutical formulation and manufacturing of personalized medicines
Gupta, A., Vaidya, K., & Boehnke, N. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91819-0.00006-3 · Cited by 6
Lee, N., Rhee, S., Koo, S. M., Kim, S. W., Lee, G. E., Yie, Y. A., & Kim, Y. (2025) · Clinical and Translational Science · doi:10.1111/cts.70125 · Cited by 4
Artificial Intelligence [AI] -The Game Changer in Pharmaceutical Industry
Fatima, M. J., & Parthiban, C. (2024) · Asian Journal of Pharmacy and Technology · doi:10.52711/2231-5713.2024.00061 · Cited by 4
A Review on Progress and Potential of Machine Learning and AI in Pharmaceutical Development
Uriti, S. V. (2025) · Journal of Pharma Insights and Research. · doi:10.69613/8pyky553 · Cited by 4
Dagher, J., Nassar, M., & Faour, W. H. (2025) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2025.178183 · Cited by 5
Artificial Intelligence-Based Methods and Omics for Mental Illness Diagnosis: A Review
de Oliveira, G. S., Rodrigues, F. H. D. S., Pontes, J. G. D. M., & Tasić, L. (2025) · Bioengineering · doi:10.3390/bioengineering12101039 · Cited by 4
Mesenchymal stem cell therapy for end-stage liver disease: adversity and opportunity
Li, S., Wang, Y., Li, S., Zhu, Y., Du, Y., Zheng, X., & Wu, J. (2025) · Stem Cell Research & Therapy · doi:10.1186/s13287-025-04788-3 · Cited by 6
Dong, K., Liu, F., Zhang, M., Zhou, Y., Yu, F., Wang, W., Chai, X., Li, J., & Song, G. (2026) · Molecular Therapy · doi:10.1016/j.ymthe.2026.01.031 · Cited by 4
A meta learning and task adaptive approach for drug target affinity prediction
Wan, M., Zhao, Y., Zhang, Y., Xu, H., Yi, D., Zan, P., He, S., & Bo, X. (2026) · Nature Communications · doi:10.1038/s41467-026-70554-5 · Cited by 4
Physics-inspired explainable AI for mechanistic and decision support in drug discovery
Lavecchia, A. (2026) · Drug Discovery Today · doi:10.1016/j.drudis.2026.104679 · Cited by 4
Advances in Activity/Property Prediction from Chemical Structures
Saunders, A., & Harrington, P. D. B. (2022) · Critical Reviews in Analytical Chemistry · doi:10.1080/10408347.2022.2066461 · Cited by 4
Small Molecular Drug Screening Based on Clinical Therapeutic Effect
Cai, Z., Ai, J., Yang, Y., Ma, F., & Sun, W. H. (2022) · Molecules · doi:10.3390/molecules27154807 · Cited by 4
General Strategies for Rational Design and Discovery of Multitarget Drugs
Wang, Z., & Yang, B. (2022) · Springer eBooks · doi:10.1007/978-3-031-04998-9_18 · Cited by 4
The Role of Artificial Intelligence in Therapeutic Drug Monitoring and Clinical Toxicity
Saikia, S., Prajapati, J. B., Prajapati, B. G., Padma, V. V., & Pathak, Y. V. (2022) · Springer eBooks · doi:10.1007/978-3-031-12398-6_5 · Cited by 5
Platinum(IV) compounds as potential drugs: a quantitative structure-activity relationship study
Novak, J., Романовна, З. А., Potemkin, V., Шарутин, В. В., & Sharutina, O. K. (2023) · Bioimpacts · doi:10.34172/bi.2023.24180 · Cited by 4
Building a Convolutional Neural Network Model for Tuberculosis Detection Using Chest X-Ray Images
Akbari, M. N., & Azizi, A. (2023) · ghalib quarterly journal · doi:10.58342/ajid/ghalibuni.v.1.i.1.5 · Cited by 4
Kim, Y., Atukeren, E., & Lee, Y. W. (2023) · International Journal of Global Business and Competitiveness · doi:10.1007/s42943-023-00080-4 · Cited by 4
Vatchalan, L., Gomathi, V., Rajeshkanna, A., & Hari Ram, S. (2023) · Indian Journal of Biochemistry and Biophysics · doi:10.56042/ijbb.v60i11.6067 · Cited by 4
Overview of drugs approved by the FDA in 2022
Куркин, Д. В., Morkovin, E. I., Bakulin, D. A., Gorbunova, Y. V., Kolosov, Y. A., Dzhavakhyan, M. A., Макаренко, И. Е., Васильевич, Д. Р., Zaborovsky, A. V., Shatalova, O. V., et al. (2023) · Pharmacy & Pharmacology · doi:10.19163/2307-9266-2023-11-3-193-210 · Cited by 4
Jain, D., Chandra, P., Ali, Z., Fatma, N., & Khan, H. (2024) · Current Drug Discovery Technologies · doi:10.2174/0115701638313233240830132804 · Cited by 4
Thiosemicarbazone Derivatives in Search of Potent Medicinal Agents: QSAR Approach (A Review)
Ahmad, M. I., Veg, E., Joshi, S., Khan, A. R., & Khan, T. (2024) · Russian Journal of General Chemistry · doi:10.1134/s1070363224090251 · Cited by 4
Sato, Y., Kashiwakura, I., Yamaguchi, M., Yoshino, H., Tanaka, T., Ikeda, K., Ye, Z., Komatsu, H., Matsuzaki, T., & Hosoda, M. (2021) · Medicinal Chemistry · doi:10.2174/1573406418666211116144243 · Cited by 4
USE OF ARTIFICIAL INTELLIGENCE IN IN SILICO DRUG DISCOVERY OF PHARMACEUTICALS
Bhattacharyya, S., & Ramakrishna, K. H. (2022) · INDIAN DRUGS · doi:10.53879/id.58.12.12316 · Cited by 4
Jhawat, V., Gupta, S., Gulia, M., & Nair, A. B. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-98352-5.00005-7 · Cited by 4
Reinventing Therapeutic Proteins: Mining a Treasure of New Therapies
Niazi, S. K., & Mariam, Z. (2023) · Biologics · doi:10.3390/biologics3020005 · Cited by 4
Villalona-Calero, M. A., Malhotra, J. D., Chung, V. M., Xing, Y., Gray, S. W., Hampel, H., Gruber, S. B., & McDonnell, K. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12124061 · Cited by 4
Mbatha, S. Z., Mulaudzi, T. V., Mbita, Z., Adeola, H. A., Batra, J., Blenman, K., & Dlamini, Z. (2023) · Springer eBooks · doi:10.1007/978-3-031-36461-7_7 · Cited by 5
Aich, K., Kashyap, S., Tyagi, K., Verma, I., Chauhan, A., & Jain, C. K. (2023) · OBM Neurobiology · doi:10.21926/obm.neurobiol.2304198 · Cited by 4
Bhat, B. A., Algaissi, A. A., Khamjan, N. A., Dar, T. U. H., Dar, S. A., Varadharajan, V., Qasir, N. A., & Lohani, M. (2024) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2023.2297006 · Cited by 4
Pareek, V., Tuteja, L., Sharma, L. K., Kumar, S., & Verma, N. (2023) · Journal of Pharmaceutical Research · doi:10.18579/jopcr/v22.3.23.54 · Cited by 4
Léger, S. J., Marchetti, B., Ashfold, M. N. R., & Karsili, T. N. V. (2020) · Frontiers in Chemistry · doi:10.3389/fchem.2020.596590 · Cited by 4
Machine Learning Applications in Rational Drug Discovery
Chugh, H., & Singh, S. (2022) · doi:10.1002/9781394167258.ch3 · Cited by 4
Rethinking medical innovation: organizing R&D, responding to crisis, delivering health services
Rake, B., Gulbrandsen, M., McKelvey, M., & Miller, F. A. (2025) · Innovation · doi:10.1080/14479338.2024.2446894 · Cited by 4
Artificial intelligence in drug discovery: Current applications and future directions
Alanazi, A. A. A., Fahad, . I. A. A., Almorshed, A. S. A., Alrbian, A. A. M., Alnughaymishi, A. A. S., Al-Mutairi, N. H. B., Alajmi, A. A., & Otaibi, S. G. A. (2022) · International Journal of Health Sciences · doi:10.53730/ijhs.v6ns10.15290 · Cited by 5
Mansur, M. C. (2025) · European Journal of Artificial Intelligence and Machine Learning · doi:10.24018/ejai.2025.4.3.65 · Cited by 3
Masoomkhah, S. S., Rezaee, K., Ansari, M., Eslami, H., Shirani, S., & Alizadeh, M. H. (2025) · Scientific Reports · doi:10.1038/s41598-025-18091-x · Cited by 3
Impact of Artificial Intelligence on the Future of Clinical Pharmacy and Hospital Settings
Hamishehkar, H., & Shahidi, M. (2025) · Journal of Research in Pharmacy Practice · doi:10.4103/jrpp.jrpp_51_25 · Cited by 7
Leveraging artificial intelligence for drug development and drug discovery
Chatterjee, S., Kundu, S., & Sarkar, N. (2025) · Elsevier eBooks · doi:10.1016/b978-0-443-33032-2.00018-6 · Cited by 3
Artificial intelligence in natural products research
Yuan, X., Yang, X., Pan, Q., Luo, C. Y., Luan, X., & Zhang, H. (2025) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(25)60902-2 · Cited by 4
Nasr, Z. G., Mohamed, A. R., Almarri, H., Amir, N., Rustom, R., Kattan, L., & Abulola, S. M. (2025) · American Journal of Pharmaceutical Education · doi:10.1016/j.ajpe.2025.101906 · Cited by 3
Bridging the digital divide in the pharmaceutical industry: A future research agenda
Miozza, M., Lombardo, S. M., Galvagno, M., & Magni, L. (2025) · Social Science & Medicine · doi:10.1016/j.socscimed.2025.118832 · Cited by 7
Sartaj, A., Rajora, A., Usmani, J., Bana, S., Annu, & Ali, J. (2025) · Journal of Pharmaceutical Innovation · doi:10.1007/s12247-025-10244-9 · Cited by 5
Fung, M.-C. (2026) · Medical Review · doi:10.1515/mr-2025-0074 · Cited by 3
Braddock, M., & Jeziorski, K. (2026) · Expert Opinion on Drug Discovery · doi:10.1080/17460441.2026.2624023 · Cited by 3
Spectral Decomposition of Chemical Semantics for Activity Cliffs‐Aware Molecular Property Prediction
Xie, C., Xu, J., Huang, G., Wang, S., He, M., Dong, X., Hong, H., Yao, X., Wang, Q., & Li, Y. (2026) · Advanced Science · doi:10.1002/advs.202517579 · Cited by 3
Hooshmandi, S., Tabatabaii, M., Arani, H. Z., Heidarian, A., & Nazemi, S. (2026) · Discover Artificial Intelligence · doi:10.1007/s44163-026-00843-x · Cited by 3
Tok, F., Dumani, A., Güney, S., Abas, B. İ., Kozan, B., Türkeş, C., Duran, H. E., Başoğlu, F., Çevik, Ö., & Ece, A. (2026) · Journal of Molecular Liquids · doi:10.1016/j.molliq.2026.129456 · Cited by 3
Singh, D., & Bhattacharya, S. (2026) · Therapeutic Delivery · doi:10.1080/20415990.2026.2662808 · Cited by 3
Jang, Y. E., Kwon, M., Kwon, C. W., Kim, S. G., Hwang, J. S., George, N. P., Paik, S. R., Misra, S., Basith, S., Sheen, S. S., et al. (2026) · Pharmaceutics · doi:10.3390/pharmaceutics18050537 · Cited by 5
From Molecular Networks to Medicines: Targeting Complexity in Alzheimer’s Disease (AD) Therapy
Kumar, D. R. P., Patel, S., Mishra, P. S., Srivastava, S., Sridhar, S. B., Shareef, J., Sahu, R., Tariq, M., Uddin, J., & Muhsinah, A. B. (2026) · Molecular Neurobiology · doi:10.1007/s12035-026-05909-6 · Cited by 3
A Note on Robotics and Artificial Intelligence in Pharmacy
Bhattacharya, S. (2021) · Applied Drug Research Clinical Trials and Regulatory Affairs · doi:10.2174/2667337108666211206151551 · Cited by 4
Artificial Intelligence in Healthcare: An Overview
Anwar, S. S., Ahmad, U., Khan, M. M., Haider, M. F., & Akhtar, J. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.102768 · Cited by 6
Progressing Towards a Human-Centric Approach in Cancer Research
Parekh, A., Das, S., Das, C. K., & Mandal, M. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.896633 · Cited by 4
Artificial Intelligence in Drug Discovery and Delivery: Advancements and Applications
Mahjoub, M. A., & Sheikholislam, Z. (2023) · Journal of Biomedical Research & Environmental Sciences · doi:10.37871/jbres1778 · Cited by 5
Predicting Quality Medical Drug Data Towards Meaningful Data using Machine Learning
Al-Showarah, S., Al-Taie, A., Salman, H. E., Alzyadat, W., & Alkhalaileh, M. S. (2023) · International Journal of Advanced Computer Science and Applications · doi:10.14569/ijacsa.2023.01408114 · Cited by 3
The Role of Artificial Intelligence and Machine Learning for the Fight Against COVID-19
Iglesias, A., Gálvez, A., & Suárez, P. (2023) · Springer optimization and its applications · doi:10.1007/978-3-031-33183-1_7 · Cited by 3
Sharma, A. (2023) · Nanomedicine & Nanotechnology Open Access · doi:10.23880/nnoa-16000232 · Cited by 3
Development Strategies for Artificial Intelligence and Robotics in Medicine
Han, X., Zhu, X., Jiang, Y., He, D., Liu, W., Duan, X., & Tian, W. Q. (2023) · Strategic Study of CAE · doi:10.15302/j-sscae-2023.07.031 · Cited by 3
Singh, P. K., Sachan, K., Khandelwal, V., Singh, S., & Singh, S. (2024) · Recent Patents on Biotechnology · doi:10.2174/0118722083297406240313090140 · Cited by 3
Applications of Artificial Intelligence in Pharmaceutical Research: An Extensive Review
Nihalani, G., & Pawar, H. A. (2024) · Bioequivalence & Bioavailability International Journal · doi:10.23880/beba-16000231 · Cited by 3
Revolutionizing Drug Discovery: The Role of Artificial Intelligence
Shah, B. (2023) · International Journal of Science and Research (IJSR) · doi:10.21275/sr231219092956 · Cited by 3
A Review on Artificial Intelligence in Pharmacy
Mahajan, B. S., Mahale, B. S. P., Pawar, A. R., Patil, V. V., Patil, P. S., & Songire, J. (2024) · Research Journal of Science and Technology · doi:10.52711/2349-2988.2024.00020 · Cited by 4
Zhang, J., Luo, W., Cui, Y., & Sun, B. (2025) · Respiratory Research · doi:10.1186/s12931-025-03207-8 · Cited by 3
Chadha, S., Mukherjee, S., & Sanyal, S. (2025) · Seminars in Oncology · doi:10.1016/j.seminoncol.2025.152349 · Cited by 6
Roldán, E., Reeves, N. D., Cooper, G., & Andrews, K. D. (2025) · Computer Methods in Biomechanics & Biomedical Engineering · doi:10.1080/10255842.2025.2551846 · Cited by 4
Key points to succeed in Artificial Intelligence drug discovery projects
Perron, Q., da Silva, V. B. R., Atwood, B. R., & Gaston‐Mathé, Y. (2022) · Chemistry International · doi:10.1515/ci-2022-0106 · Cited by 4
Prabha, T., Venkatesan, J., Selvaraj, J., Jayapalan, S., & Sivakumar, T. (2022) · Letters in Drug Design & Discovery · doi:10.2174/1570180819666220420092723 · Cited by 3
Role of Biomarkers in Personalized Medicine
Islam, S. U., Ahmed, M. B., Ahsan, H., & Lee, Y. S. (2022) · Springer eBooks · doi:10.1007/978-981-16-5759-7_10 · Cited by 4
Multiple Sclerosis - Genetics, Disease Mechanisms and Clinical Developments
Kishore, U., & Shastri, A. (2022) · IntechOpen eBooks · doi:10.5772/intechopen.98110 · Cited by 3
Artificial Intelligence Implications in Engineering and Production
Tiwari, S. (2022) · International Electronic Conference on Applied Sciences (ASEC) · doi:10.3390/asec2022-13823 · Cited by 4
Artificial intelligence in healthcare
Argenson, A., & Devi-Chou, V. (2023) · Principles of Gender-Specific Medicine · doi:10.1016/b978-0-323-88534-8.00025-0 · Cited by 3
Sestino, A., & D’Angelo, A. (2023) · Springer eBooks · doi:10.1007/978-3-031-32614-1_17 · Cited by 3
Das, D. R., Satpathy, I., & Patnaik, B. C. M. (2023) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-0876-9.ch007 · Cited by 3
Sharma, R., Gulati, A., & Chopra, K. (2023) · Springer eBooks · doi:10.1007/978-981-99-6472-7_2 · Cited by 4
A Review on Artificial Intellegence in Drug Discovery & Pharmaceutical Industry
Laddha, C. S., Shelke, A., Vaidya, Y. V., Sheikh, A. A., & Biyani, K. R. (2023) · Asian Journal of Pharmaceutical Research and Development · doi:10.22270/ajprd.v11i3.1252 · Cited by 3
Artificial intelligence applications in disease diagnosis and treatment: recent progress and outlook
Goswami, M., Sachan, P., & Goswami, K. (2023) · Research in Pharmacy · doi:10.25081/rip.2023.v13.8632 · Cited by 3
Computational Approaches for the Inhibition of ESKAPE Pathogens
Pattnaik, S., Mishra, M., & Naik, P. K. (2024) · Springer eBooks · doi:10.1007/978-981-99-8799-3_19 · Cited by 3
Consumer Perspectives for Purchase Intentions of Online Pharmacy Products Using Deep Learning
Chatterjee, J., Neogi, S. G., Dwivedi, R. K., & Vashisht, A. (2024) · International Conference on Reliability, Infocom Technologies and Optimization (Trends and Future Directions) (ICRITO) · doi:10.1109/icrito61523.2024.10522354 · Cited by 4
Metadata
- Authors
- Mak, K.-K., & Pichika, M. R.
- Affiliations
- IMU University (MY)
- Corresponding author
- Pichika, Mallikarjuna Rao
- Venue
- Drug Discovery Today
- Publisher
- Elsevier BV
- Published
- 2019-03
- Volume
- 24
- Issue
- 3
- Pages
- 773-780
- ISSN
- 1359-6446 (ISSN-L)
- OpenAlex
- W2901411193
- Cited by
- 1,018
- References
- 73
- Citations by year
- 2026: 161 · 2025: 196 · 2024: 190 · 2023: 170 · 2022: 99 · 2021: 119 · 2020: 63 · 2019: 18
- FWCI
- 3.94
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Drug Discovery Today (publishedVersion)
- PubMed (publishedVersion)
- Funders
- International Medical University
- Topics
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Drug Discovery › Computational Drug Discovery Methods
- Health Sciences › Medicine › Health Informatics › Artificial Intelligence in Healthcare and Education
- Physical Sciences › Computer Science › Artificial Intelligence › Artificial Intelligence Applications
- Keywords
- artificial intelligence, drug development, drug discovery, attrition rates, research and development costs, pharmaceutical industry
- MeSH terms
- Artificial Intelligence, Drug Industry, Humans, Drug Discovery
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review